These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34534396)

  • 1. Management of ganciclovir resistance cytomegalovirus infection with CMV hyperimmune globulin and leflunomide in seven cardiothoracic transplant recipients and literature review.
    Santhanakrishnan K; Yonan N; Iyer K; Callan P; Al-Aloul M; Venkateswaran R
    Transpl Infect Dis; 2022 Feb; 24(1):e13733. PubMed ID: 34534396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.
    Isada CM; Yen-Lieberman B; Lurain NS; Schilz R; Kohn D; Longworth DL; Taege AJ; Mossad SB; Maurer J; Flechner SM; Mawhorter SD; Braun W; Gordon SM; Schmitt SK; Goldman M; Long J; Haug M; Avery RK
    Transpl Infect Dis; 2002 Dec; 4(4):189-94. PubMed ID: 12535261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.
    Fisher CE; Knudsen JL; Lease ED; Jerome KR; Rakita RM; Boeckh M; Limaye AP
    Clin Infect Dis; 2017 Jul; 65(1):57-63. PubMed ID: 28369203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
    Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
    Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.
    Majeed A; Latif A; Kapoor V; Sohail A; Florita C; Georgescu A; Zangeneh T
    Transplant Proc; 2018 Dec; 50(10):3756-3762. PubMed ID: 30586840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature.
    Hofmann E; Sidler D; Dahdal S; Bittel P; Suter-Riniker F; Manuel O; Walti LN; Hirzel C
    Transpl Infect Dis; 2021 Jun; 23(3):e13515. PubMed ID: 33210830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection.
    Mehta Steinke SA; Alfares M; Valsamakis A; Shoham S; Arav-Boger R; Lees L; Ostrander D; Forman MS; Shedeck A; Ambinder RF; Jones RJ; Avery RK
    Transpl Infect Dis; 2021 Jun; 23(3):e13521. PubMed ID: 33220125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the management of cytomegalovirus infection after solid organ transplantation.
    Eid AJ; Razonable RR
    Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Cidofovir for Cytomegalovirus Disease Refractory to Ganciclovir in Solid Organ Recipients.
    Bonatti H; Sifri CD; Larcher C; Schneeberger S; Kotton C; Geltner C
    Surg Infect (Larchmt); 2017; 18(2):128-136. PubMed ID: 27849440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganciclovir-Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the Literature.
    Rolling KE; Jorgenson MR; Descourouez JL; Mandelbrot DA; Redfield RR; Smith JA
    Pharmacotherapy; 2017 Oct; 37(10):1258-1271. PubMed ID: 28699311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.
    Gagermeier JP; Rusinak JD; Lurain NS; Alex CG; Dilling DF; Wigfield CH; Love RB
    Transpl Infect Dis; 2014 Dec; 16(6):941-50. PubMed ID: 25491023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
    Verkaik NJ; Hoek RA; van Bergeijk H; van Hal PT; Schipper ME; Pas SD; Beersma MF; Boucher CA; Jedema I; Falkenburg F; Hoogsteden HC; van den Blink B; Murk JL
    Transpl Infect Dis; 2013 Dec; 15(6):E243-9. PubMed ID: 24298985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches.
    Fu L; Santhanakrishnan K; Al-Aloul M; Jones NP; Steeples LR
    Ocul Immunol Inflamm; 2020 Oct; 28(7):1152-1158. PubMed ID: 31621449
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature.
    Silva JT; Pérez-González V; Lopez-Medrano F; Alonso-Moralejo R; Fernández-Ruiz M; San-Juan R; Brañas P; Folgueira MD; Aguado JM; de Pablo-Gafas A
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29226391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
    Jung JY; Nho D; Cho SY; Lee DG; Choi SM; Kim HJ; Kim M; Oh EJ
    J Infect Chemother; 2022 Oct; 28(10):1415-1418. PubMed ID: 35810104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
    Noble S; Faulds D
    Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.
    Kneidinger N; Giessen C; von Wulffen W; Milger K; Schramm R; Jäger G; Nitschko H; Striebinger H; Behr J; Neurohr C
    Int J Infect Dis; 2014 Nov; 28():140-2. PubMed ID: 25267276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J; Rotjanapan P; Watcharananan SP
    Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Genotypic Resistance and Outcome Among Solid Organ Transplant Recipients With Refractory Cytomegalovirus Infection.
    Tamzali Y; Pourcher V; Azoyan L; Ouali N; Barrou B; Conti F; Coutance G; Gay F; Tourret J; Boutolleau D
    Transpl Int; 2023; 36():11295. PubMed ID: 37398559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.